Some metabolic effects of the endocrine treatment of recurrent and metastatic carcinoma of the breast

J A STRONG et al. Acta Endocrinol Suppl (Copenh). 1957.

. 1957;24(Suppl 31):294-306.

doi: 10.1530/acta.0.024s294.

No abstract available

Similar articles

Endocrine treatment of metastatic cancer of the breast and prostate.
LUFT R, OLIVERCRONA H, IKKOS D. LUFT R, et al. Acta Endocrinol Suppl (Copenh). 1957;24(Suppl 31):241-53. doi: 10.1530/acta.0.024s241. Acta Endocrinol Suppl (Copenh). 1957. PMID: 13443784 No abstract available.
Endocrine therapy of metastatic breast cancer.
LIPSETT MB, PEARSON OH. LIPSETT MB, et al. Postgrad Med. 1957 Jun;21(6):571-6. doi: 10.1080/00325481.1957.11691813. Postgrad Med. 1957. PMID: 13431580 No abstract available.
Aspects on endocrine treatment of prostatic and breast cancer.
HELLSTROM J, HULTBERG S, WESTMAN A, BIRKE G, DICZFALUSY E, FRANKSSON C, PLANTIN LO. HELLSTROM J, et al. Acta Endocrinol Suppl (Copenh). 1957;24(Suppl 31):261-72. doi: 10.1530/acta.0.024s261. Acta Endocrinol Suppl (Copenh). 1957. PMID: 13443786 No abstract available.
Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
Wittliff JL, Day TG Jr, Dean WL, Allegra JC. Wittliff JL, et al. Prog Clin Biol Res. 1988;276:11-41. Prog Clin Biol Res. 1988. PMID: 3051018 Review. No abstract available.
[Hormone therapy of breast carcinoma in men].
Doberauer C, Niederle N. Doberauer C, et al. Dtsch Med Wochenschr. 1990 Nov 16;115(46):1762-8. doi: 10.1055/s-2008-1065224. Dtsch Med Wochenschr. 1990. PMID: 2171893 Review. German. No abstract available.